Mostrar el registro sencillo del ítem

dc.contributor.author
Bardach, Ariel Esteban  
dc.contributor.author
Espinola, Natalia Micaela  
dc.contributor.author
Rodríguez Cairoli, Federico  
dc.contributor.author
Perelli, Lucas  
dc.contributor.author
Balan, Darío  
dc.contributor.author
Palacios, Alfredo  
dc.contributor.author
Augustovski, Federico Ariel  
dc.contributor.author
Pichón-Riviere, Andrés  
dc.contributor.author
Alcaraz, Andrea  
dc.date.available
2024-02-29T14:20:00Z  
dc.date.issued
2023-02  
dc.identifier.citation
Bardach, Ariel Esteban; Espinola, Natalia Micaela; Rodríguez Cairoli, Federico; Perelli, Lucas; Balan, Darío; et al.; The burden of disease and economic impact of sugar-sweetened beverages' consumption in Argentina: A modeling study; Public Library of Science; Plos One; 18; 2-2023; 1-17  
dc.identifier.issn
1932-6203  
dc.identifier.uri
http://hdl.handle.net/11336/228956  
dc.description.abstract
Background Approximately two-thirds of Argentine adults are overweight or obese, and 11% have diabetes. Over the last two decades, all population groups have increased their consumption of ultra-processed foods and sugar-sweetened beverages (SSB). We aimed to estimate the disease burden-deaths, events, and costs to the health system-attributed to SSB consumption in Argentina. Methods We used a comparative risk assessment framework to estimate the health and economic impacts that would be avoided in a scenario without sugar-sweetened beverage (SSB) consumption. We calculated the direct effects on diabetes, cardiovascular disease, and BMI, and then estimated the effects of BMI on disease incidence. Finally, we applied the population attributable factor to calculate the health and economic burden avoided in Argentina in 2020. Results Our model estimated that about 4,425 deaths, 110,000 healthy life years lost to premature death and disability, more than 520,000 cases of overweight and obesity in adults, and 774,000 in children and adolescents would be attributed to SSB Consumption in Argentina. This disease burden corresponds to 23% of type-2 diabetes cases and other significant proportions of cardiovascular disease and cancer. The overweight and obesity costs attributable to SSB totaled approximately $47 million in adults and $15 million in children and adolescents. Conclusion A significant number of disease cases, deaths, and health care costs could be attributed to SSB consumption in Argentina. Implementing measures to reduce the sugar content in beverages is a pending debt for the country and could lead to measurable improvements in population health, especially among children and adolescents.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Public Library of Science  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Risk assessment  
dc.subject
Health and economic impacts  
dc.subject
Sugar-sweetened beverage  
dc.subject
Overweight  
dc.subject.classification
Políticas y Servicios de Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
The burden of disease and economic impact of sugar-sweetened beverages' consumption in Argentina: A modeling study  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2024-02-28T10:11:15Z  
dc.journal.volume
18  
dc.journal.pagination
1-17  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
San Francisco  
dc.description.fil
Fil: Bardach, Ariel Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina  
dc.description.fil
Fil: Espinola, Natalia Micaela. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Rodríguez Cairoli, Federico. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Perelli, Lucas. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Balan, Darío. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Palacios, Alfredo. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Augustovski, Federico Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina  
dc.description.fil
Fil: Pichón-Riviere, Andrés. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina  
dc.description.fil
Fil: Alcaraz, Andrea. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.journal.title
Plos One  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1371/journal.pone.0279978  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0279978